NDAORALTABLET
Approved
Jan 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
11
Mechanism of Action
Guanylate Cyclase Activators
Pharmacologic Class:
Guanylate Cyclase-C Agonist
Clinical Trials (5)
Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)
Started Jun 2018
A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
Started Jun 2018
An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation
Started Jan 2017
Long Term Safety Study of Plecanatide
Started Jan 2016
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Started Jun 2015
Loss of Exclusivity
LOE Date
Jun 5, 2034
100 months away
Patent Expiry
Jun 5, 2034